Unknown

Dataset Information

0

Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.


ABSTRACT:

Background

Locally advanced esophageal carcinoma (LAEC) represents less than 30% of all diagnosed esophageal carcinoma worldwide. The standard of care for resectable tumours consists of preoperative chemoradiotherapy (CRT) followed by surgery. Despite the curative intent, the prognosis is still poor mainly due to relapse. A multidisciplinary approach is required in order to optimize the therapeutic strategy and follow-up. Differences in outcomes between the two main histological subtypes, adenocarcinoma (ADC) and squamous cell carcinoma (SCC), have been reported. Nevertheless, the heterogeneity in trials design and data available have hampered the achievement of clear conclusions. The purpose of this study is to report the outcomes from a cohort of patients with LAEC treated with a multidisciplinary approach and to remark the differences observed between the two main histologic subtypes and their clinical implications.

Methods

We retrospectively reviewed 100 patients diagnosed with LAEC that were treated with preoperative CRT at our institution and integrated centres. Histopathological characteristics and toxicities during treatment were recorded. Patterns of recurrence at the first relapse were analysed. Survival curves were plotted using the Kaplan Meier method and multivariate Cox proportional hazards models were used.

Results

Among the patients who received preoperative CRT, 83% underwent surgery. The median overall survival (mOS) was 31.7 months, 26.9 months for ADC and 45.5 for SCC (p-value = 0.33). In the multivariate Cox regression analysis, ypN+ was the only factor that negatively influenced in OS (OR = 4.1, p-value = 0.022). Patterns of recurrence differed according to histologic subtype. Distant relapse was more frequent in ADC (62%), whereas locoregional relapse was higher in SCC (50%) (p-value = 0.027). Second line therapeutic strategies could be offered to 50% of those patients who relapsed.

Conclusions

Differences in outcomes and recurrence pattern could be observed between the two main histologic subtypes of LAEC. A better molecular characterization, adapted therapeutic regimens and follow up strategies should be adopted in order to improve survival of these patients.

SUBMITTER: Saigi M 

PROVIDER: S-EPMC5607166 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.

Saigí Maria M   Oliva Marc M   Aliste Luisa L   Calvo Mariona M   Hormigo Gloria G   Serra Òlbia Ò   Boladeras Anna A   Farran Leandre L   Robles Javier J   Creus Gloria G   Paúles Ma José MJ   Gornals Joan B JB   de Lama Eugenia E   Borràs Josep Ma JM   Sala Núria N   Galán Maica M  

PloS one 20170920 9


<h4>Background</h4>Locally advanced esophageal carcinoma (LAEC) represents less than 30% of all diagnosed esophageal carcinoma worldwide. The standard of care for resectable tumours consists of preoperative chemoradiotherapy (CRT) followed by surgery. Despite the curative intent, the prognosis is still poor mainly due to relapse. A multidisciplinary approach is required in order to optimize the therapeutic strategy and follow-up. Differences in outcomes between the two main histological subtypes  ...[more]

Similar Datasets

| S-EPMC10331751 | biostudies-literature
| S-EPMC11406992 | biostudies-literature
| S-EPMC6046100 | biostudies-literature
| S-EPMC11428459 | biostudies-literature
| S-EPMC7779346 | biostudies-literature
| S-EPMC8114152 | biostudies-literature
| S-EPMC10921522 | biostudies-literature
| S-EPMC8157673 | biostudies-literature
| S-EPMC9599968 | biostudies-literature